[1]
K. B. D. S. Melati, A. Hardaetha, and W. . Kusuma, “The Effectiveness of Meloxicam Adjuvant Therapy against Negative Symptoms and Neutrophil Lymphocyte Ratio (NLR) in Schizophrenic Patients”, JUXTA, vol. 14, no. 2, pp. 57–62, Aug. 2023.